Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Recursion Pharmaceuticals Inc (RXRX)

  • Event
  • June 09, 2022, 21:00 UTC
  • 11
  • 1 comments

(99% Neutral) RECURSION PHARMACEUTICALS, INC. (RXRX) Announces New Board Appointment

Comment Full text

MeiraGTx Holding (MGTX)

  • Event
  • June 09, 2022, 20:31 UTC
  • 11
  • 1 comments

(99% Neutral) MeiraGTx Holdings plc (MGTX) Files Form 8-K

Comment Full text

Solid Biosciences Inc (SLDB)

  • Event
  • June 09, 2022, 20:30 UTC
  • 11
  • 1 comments

(99% Neutral) Solid Biosciences Inc. (SLDB) Announces Regulatory Update

Comment Full text

Illumina Inc (ILMN)

  • Event
  • June 09, 2022, 20:18 UTC
  • 11
  • 1 comments

(99% Neutral) Illumina, Inc. (ILMN) Announces Executive Departure

Comment Full text

Forma Therapeutics Holdings Inc (the company became a subdivision of the company Novo Nordisk (NYSE: NVO)) (FMTX)

  • Event
  • June 09, 2022, 20:08 UTC
  • 11
  • 1 comments

(99% Neutral) FORMA THERAPEUTICS HOLDINGS, INC. (FMTX) Announces Regulatory Update

Comment Full text

Reata Pharmaceuticals Inc (was by Biogen Inc. (Nasdaq: BIIB) on 26/09/2023) (RETA)

  • Event
  • June 09, 2022, 20:07 UTC
  • 10
  • 1 comments

(99% Neutral) Reata Pharmaceuticals, Inc. (RETA) Announces New Board Appointment

Comment Full text

Fulcrum Therapeutics (FULC)

  • Event
  • June 09, 2022, 20:06 UTC
  • 10
  • 1 comments

(99% Neutral) FULCRUM THERAPEUTICS, INC. (FULC) Files Form 8-K

Comment Full text

Sana Biotechnology Inc (SANA)

  • Event
  • June 09, 2022, 20:06 UTC
  • 11
  • 1 comments

(99% Neutral) SANA BIOTECHNOLOGY, INC. (SANA) Files Form 8-K

Comment Full text

Paratek Pharmaceuticals Inc (was acquised by Gurnet Point Capital ("Gurnet Point") and Novo Holdings A/S ("Novo Holdings") on 21/09/2023) (PRTK)

  • Event
  • June 09, 2022, 20:05 UTC
  • 11
  • 1 comments

(99% Neutral) PARATEK PHARMACEUTICALS, INC. (PRTK) Announces Regulatory Update

Comment Full text

Genmab (GMAB)

  • Event
  • June 09, 2022, 19:19 UTC
  • 10
  • 1 comments

(99% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K)

Comment Full text
  • Previous
  • 187
  • 188
  • 189
  • 190
  • 191
  • Next

Search

News categories

  • Technical Exchange News(10877)
  • Event(2252)
  • SEC News(189194)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124557)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin